Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Canon, Inc. v. TCL Electronics Holdings, Ltd.
Case Number:
3:20-mc-80079
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
May 15, 2020
COVID-19 IP Catch-Up: Source Code Woes, Generic Antivirals
The Federal Circuit will continue to hold remote oral arguments into the summer, Gilead is allowing some generic-drug makers to produce versions of its antiviral treatment remdesivir, and companies that are allegedly upcharging for coronavirus-related products are continuing to find themselves in court for trademark law violations.
-
May 14, 2020
Hulu Warns Remote Source Code Viewing Could Destroy Biz
Hulu has urgently pushed a California federal judge not to let Canon attorneys and experts access Roku's source code remotely due to COVID-19 restrictions, a plea that will now be decided by the Texas judge overseeing underlying infringement litigation.
-
May 08, 2020
COVID-19 IP Catch-Up: USPTO Gets Busy, Zoom Trial Begins
The U.S. Patent and Trademark Office has issued a new update almost every day lately about how the pandemic is affecting its operations. Meanwhile, coronavirus-related issues also have been in play in court, leading to a patent trial conducted over Zoom, a fight over accessing Roku's source code remotely and more.